← 返回

B-ALL 患者中 CAR-T 细胞的功能多样化与动态变化

英文原题:Functional diversification and dynamics of CAR-T cells in patients with B-ALL.

查看英文原题

Functional diversification and dynamics of CAR-T cells in patients with B-ALL.

PubMed 2023/10/17(内容时间) Cell Rep Q1 · IF 7.7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

CAR-T 输注后的细胞演变和分子程序研究,对于制定更优治疗策略至关重要。本研究构建了纵向高精度单细胞转录组图谱,分析了26例B细胞急性淋巴细胞白血病(B-ALL)患者输注后共7,578个CAR-T 细胞。研究分子鉴定出8种CAR-T 细胞亚型,其中包括具有不同动力学特征的3种细胞毒性亚型,以及3种呈现非T细胞特征的双重身份亚型。值得注意的是,长期缓解与细胞毒性亚型占主导相关;白血病进展则与出现具有B细胞转录特征、表现功能障碍且可能预示复发的亚型相关。体外实验进一步验证,过度肿瘤抗原刺激或TCR信号受抑可诱导出现B细胞特征的CAR-T 细胞,而外源性IL-12可减轻这一变化。此外,研究界定了不同CAR-T 亚型的转录特征,并揭示了体内计算推断细胞演变过程中CAR-T 细胞的分子变化。总体而言,这些结果阐明了CAR-T 细胞输注后外周细胞的功能多样化和动态变化。

展开英文摘要原文

Understanding of cellular evolution and molecular programs of chimeric antigen receptor-engineered (CAR)-T cells post-infusion is pivotal for developing better treatment strategies.

Here, we construct a longitudinal high-precision single-cell transcriptomic landscape of 7,578 CAR-T cells from 26 patients with B cell acute lymphoblastic leukemia (B-ALL) post-infusion.

We molecularly identify eight CAR-T cell subtypes, including three cytotoxic subtypes with distinct kinetics and three dual-identity subtypes with non-T cell characteristics. Remarkably, long-term remission is coincident with the dominance of cytotoxic subtypes, while leukemia progression is correlated with the emergence of subtypes with B cell transcriptional profiles, which have dysfunctional features and might predict relapse.

We further validate in vitro that the generation of B-featured CAR-T cells is induced by excessive tumor antigen stimulation or suppressed TCR signaling, while it is relieved by exogenous IL-12.

Moreover, we define transcriptional hallmarks of CAR-T cell subtypes and reveal their molecular changes along computationally inferred cellular evolution in vivo. Collectively, these results decipher functional diversification and dynamics of peripheral CAR-T cells post-infusion.

论文信息

作者
Li Z、Zhao L、Zhang Y、Zhu L、Mu W、Ge T、Jin J、Tan J
第一作者单位
State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Institute of Hematology, Senior Department of Hematology, Fifth Medical Center of Chinese PLA General Hospital, Beijing 100071, China. Electronic address: lizc07@vip.qq.com.China
通讯作者单位
Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan 432826, China; National Clinical Research Center for Hematologic Diseases, the First Affiliated Hospital of Soochow University, Suzhou 215006, China. Electronic address: lhuang@tjh.tjmu.edu.cn.China
文献类型
非美国政府资助研究
期刊
Cell reports2023 Oct 31
原文标识
PubMed 37851569 · DOI 10.1016/j.celrep.2023.113263